• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾源性系统性纤维化:单中心 15 年回顾性研究。

Nephrogenic systemic fibrosis: A 15-year retrospective study at a single tertiary care center.

机构信息

Department of Dermatology, University of Texas Medical Branch, University of Texas, Galveston, Texas.

School of Medicine, University of Texas Medical Branch, University of Texas, Galveston, Texas.

出版信息

J Am Acad Dermatol. 2017 Aug;77(2):235-240. doi: 10.1016/j.jaad.2017.02.003. Epub 2017 Mar 18.

DOI:10.1016/j.jaad.2017.02.003
PMID:28318680
Abstract

BACKGROUND

Despite multiple therapeutic approaches for nephrogenic systemic fibrosis (NSF), no single treatment has convincingly shown consistent benefit. The most successful outcomes have been associated with recovery of renal function, although evidence remains limited and past studies have been inconclusive.

OBJECTIVE

We sought to investigate whether improvement of renal function via successful transplantation or via return of renal function after acute kidney injury correlates with improvement of NSF, and to further characterize the clinical features and progression of NSF.

METHODS

A retrospective medical chart review led to the identification of patients (n = 8) diagnosed with NSF who presented to a single academic tertiary referral center over a 15-year period. These 8 patients were contacted by phone to obtain information related to treatment and clinical course of their NSF and renal function. Statistical analysis was performed using Fisher's exact test.

RESULTS

There is a significant correlation (P = .0286) of improved renal function with improvement of NSF. All 4 patients who had improvement of renal function also had improvement of NSF. Two of these patients had end-stage renal disease and a successful kidney transplant, and two had acute kidney injury that resolved. No improvement in NSF was observed without kidney function resolution.

LIMITATIONS

Our study is limited by a small sample size (n = 8) and a retrospective study design, which increased its potential for selection and recall bias.

CONCLUSION

Improvement of renal function through either transplantation or resolution of acute kidney injury with medical management is significantly associated with improvement of NSF.

摘要

背景

尽管针对肾源性系统性纤维化 (NSF) 有多种治疗方法,但没有单一的治疗方法能令人信服地显示出一致的益处。最成功的结果与肾功能的恢复有关,尽管证据仍然有限,过去的研究也没有定论。

目的

我们试图研究肾功能的改善(通过成功的移植或急性肾损伤后肾功能的恢复)是否与 NSF 的改善相关,并进一步描述 NSF 的临床特征和进展。

方法

回顾性病历审查确定了 8 名在 15 年内被诊断为 NSF 并在一家学术性三级转诊中心就诊的患者。通过电话联系这 8 名患者,以获取与他们的 NSF 和肾功能的治疗和临床病程相关的信息。使用 Fisher 精确检验进行统计分析。

结果

肾功能的改善与 NSF 的改善有显著相关性(P =.0286)。所有肾功能改善的 4 名患者也有 NSF 的改善。这 2 名患者患有终末期肾病并成功进行了肾移植,2 名患者患有急性肾损伤并得到解决。没有观察到肾功能未恢复时 NSF 的改善。

局限性

我们的研究受到样本量小(n = 8)和回顾性研究设计的限制,这增加了选择和回忆偏倚的可能性。

结论

通过移植或通过药物治疗解决急性肾损伤来改善肾功能与 NSF 的改善显著相关。

相似文献

1
Nephrogenic systemic fibrosis: A 15-year retrospective study at a single tertiary care center.肾源性系统性纤维化:单中心 15 年回顾性研究。
J Am Acad Dermatol. 2017 Aug;77(2):235-240. doi: 10.1016/j.jaad.2017.02.003. Epub 2017 Mar 18.
2
Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.6 例肾移植受者中复发性肾源性系统性纤维化:单中心经验。
J Am Acad Dermatol. 2010 Sep;63(3):389-99. doi: 10.1016/j.jaad.2009.10.038. Epub 2010 Jul 8.
3
Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.肾移植后肾源性系统性纤维化的临床改善
Clin Transplant. 2008 Nov-Dec;22(6):803-8. doi: 10.1111/j.1399-0012.2008.00886.x. Epub 2008 Aug 18.
4
Large sample of nephrogenic systemic fibrosis cases from a single institution.来自单一机构的大量肾源性系统性纤维化病例样本。
Arch Dermatol. 2009 Oct;145(10):1095-102. doi: 10.1001/archdermatol.2009.232.
5
Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.对接受注射钆贝葡胺或钆特醇磁共振成像检查的3 - 5期慢性肾脏病患者进行的肾源性系统性纤维化前瞻性队列研究。
AJR Am J Roentgenol. 2015 Sep;205(3):469-78. doi: 10.2214/AJR.14.14268.
6
Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.2000 年至 2006 年间,奥克兰大区接受透析治疗的终末期肾病患者中出现了肾源性系统性纤维化。
Nephrology (Carlton). 2011 Feb;16(2):243-8. doi: 10.1111/j.1440-1797.2010.01397.x.
7
Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.晚期慢性肾脏病中的肾源性系统性纤维化:台湾一家医院的经验
Eur J Dermatol. 2009 Jan-Feb;19(1):44-9. doi: 10.1684/ejd.2008.0545. Epub 2008 Dec 5.
8
UV-A1 therapy for nephrogenic systemic fibrosis.用于治疗肾源性系统性纤维化的UV-A1疗法。
Arch Dermatol. 2009 Oct;145(10):1170-4. doi: 10.1001/archdermatol.2009.245.
9
Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?金属转移与钆:铁储备不足能否预防高危终末期肾病患者发生肾源性系统性纤维化?
Hemodial Int. 2010 Jul;14(3):289-94. doi: 10.1111/j.1542-4758.2010.00456.x.
10
The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis.肾移植患者伴肾性系统性纤维化中钆剂与促红细胞生成素的争论。
J Nephrol. 2013 Jan-Feb;26(1):48-54. doi: 10.5301/jn.5000159.

引用本文的文献

1
The Clinical Manifestations and Efficacy of Different Treatments Used for Nephrogenic Systemic Fibrosis: A Systematic Review.肾源性系统性纤维化不同治疗方法的临床表现及疗效:一项系统评价
Int J Nephrol Renovasc Dis. 2023 Jan 12;16:17-30. doi: 10.2147/IJNRD.S392231. eCollection 2023.
2
Toxicological Assessment of Gadodiamide in Normal Brain SVG P12 Cells.gadodiamide 在正常脑 SVG P12 细胞中的毒理学评估。
In Vivo. 2021 Sep-Oct;35(5):2621-2630. doi: 10.21873/invivo.12544.
3
Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging.
2020 年影像学总结:磁共振成像展望医疗保健的未来。
Mol Imaging Biol. 2019 Apr;21(2):193-199. doi: 10.1007/s11307-019-01315-8.